IGI Inc.
Clinical Trial SponsorAt IGI, we strive to fast-track the development of new cancer cures through collaboration. We focus on creating cutting-edge solutions to treat hematological malignancies and…

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
At IGI, we strive to fast-track the development of new cancer cures through collaboration. We focus on creating cutting-edge solutions to treat hematological malignancies and…
AffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform.